Uniphar PLC Notice of AGM & Annual Report & Dividend Update (5254V)
April 06 2023 - 2:00AM
UK Regulatory
TIDMUPR
RNS Number : 5254V
Uniphar PLC
06 April 2023
Publication of Notice of Annual General Meeting and Annual
Report and Dividend Update
Dublin, London | 6 April 2023: Uniphar plc (the "Company" or
"Uniphar") wishes to announce that it is today posting to
shareholders its Notice of Annual General Meeting ("AGM") for 2023
together with its annual report and accounts for the year ended 31
December 2022 ("Annual Report"). The AGM will be held at 11.00 a.m.
on 11 May 2023 at the offices of William Fry LLP, 2 Grand Canal
Square, Dublin 2, D02 A342.
Uniphar values the participation of its shareholders at its AGM
and encourages all shareholders to take part in the meeting either
in person or by voting and raising questions in advance.
The Notice of Meeting, Form of Proxy, Annual Report and accounts
are available to view on the Company's website at
https://www.uniphar.ie/static/investors/shareholder-centre/agm/agm-2023/
and will be available for inspection during normal business hours
on any business day from today until the conclusion of the AGM at
the registered office of the Company.
Proxy voting can be carried out in advance of the AGM. Details
of how to do so are set out in further detail in the Notice of
Meeting.
A conference call facility will be provided to allow
shareholders to listen live to the business of the AGM. Please note
that you will not be able to use this facility to vote, raise
points or issues or ask questions. If you wish to listen live to
the AGM proceedings, you can register for the conference call and
receive participant log-in detailsat
https://www.uniphar.ie/static/investors/shareholder-centre/agm/agm-2023/
. Shareholders availing of this facility should ensure to submit
any votes in advance of the meeting as it will not be possible to
vote using the conference call facility.
Shareholders are invited to submit questions in writing in
advance of the meeting either by email to
companysecretary@uniphar.ie or by post to the Company Secretary,
Uniphar plc, 4045 Kingswood Road, Citywest Business Park, Co.
Dublin, D24 V06K, Ireland. Questions must be received by 11.00 a.m.
on 9 May 2023 . Shareholders must include their Shareholder
Reference Number (as set out on their Form of Proxy) with any
question submitted.
Dividend Update
This announcement also amends the final dividend amount per
share for approval at the AGM to EUR0.0113 per ordinary share, from
EUR0.011 per ordinary share as published in the 2022 preliminary
results released on 28 February 2023.
For further details contact:
Uniphar Group Tel: +353 (0) 1 428 7777
Allan Smylie, Head of Strategy and IR
Davy (Joint Corporate Broker, Nominated Advisor Tel: +353 (0) 1 679 6363
and
Euronext Growth Listing Sponsor)
Barry Murphy
Niall Gilchrist
RBC Capital Markets (Joint Corporate Broker) Tel: +44 (0) 20 7653
4000
Jonathan Hardy
Jamil Miah
Stifel Nicolaus Europe Limited (Joint Corporate Tel: + 44 (0) 20 7710
Broker) 7600
Matt Blawat
Ben Maddison
Francis North
Q4 PR Tel: +353 (0) 1 475 1444
Iarla Mongey, Public Relations Advisor to Uniphar
Group
About Uniphar plc
Headquartered in Dublin, Ireland, the Uniphar Group is an
international diversified healthcare services business servicing
the requirements of more than 200 multinational pharmaceutical and
medical technology manufacturers across three divisions -
Commercial & Clinical, Product Access and Supply Chain &
Retail. The Group is active in Europe, North America, APAC and
MENA.
The Company's vision is to improve patient access to
pharmaco-medical products and treatments by enhancing connectivity
between manufacturers and healthcare stakeholders. Uniphar
represents a strong combination of scale, growth, and
profitability.
Commercial & Clinical
In Commercial & Clinical, the Group provides outsourced
sales, marketing & distribution solutions to multinational
pharmaceutical and medical device manufacturers. Active in Ireland,
the UK, Benelux, the Nordics, Germany and the US, the Group is
growing with its clients to provide pan-European solutions, with a
targeted service offering in the US. Uniphar has built fully
integrated digitally enabled customer centric solutions that are
supported by our highly experienced and clinically trained teams,
leveraging our digital technology and insights which allows us to
deliver consistently exceptional outcomes for our clients.
Product Access
In Product Access, the Group is growing two distinct service
offerings: 1) "On Demand", which are pharmacy led solutions for
sourcing and supplying unlicensed medicines to meet the needs of
both retail and hospital pharmacists; and 2) "Exclusive Access",
which are manufacturer led solutions for controlling the release of
speciality medicines for specifically approved patient populations
in agreed markets. The Group currently delivers product access
solutions on a global basis.
Supply Chain & Retail
Uniphar is an established market leader in Ireland with c. 53%
market share in the wholesale/hospital market, supported by a
network of 423 owned, franchised and symbol group pharmacies. The
business supports the diverse customer base through the provision
of strong service levels coupled with innovative commercial
initiatives. Supply Chain & Retail is an Irish only business
for the Group, although the manufacturer relationships and
infrastructure are also utilised for the benefit of the Commercial
& Clinical and Product Access divisions.
This information is provided by RNS, the news service of the
London Stock Exchange. RNS is approved by the Financial Conduct
Authority to act as a Primary Information Provider in the United
Kingdom. Terms and conditions relating to the use and distribution
of this information may apply. For further information, please
contact rns@lseg.com or visit www.rns.com.
RNS may use your IP address to confirm compliance with the terms
and conditions, to analyse how you engage with the information
contained in this communication, and to share such analysis on an
anonymised basis with others as part of our commercial services.
For further information about how RNS and the London Stock Exchange
use the personal data you provide us, please see our Privacy
Policy.
END
NOAUPUGUCUPWGCA
(END) Dow Jones Newswires
April 06, 2023 02:00 ET (06:00 GMT)
Uniphar (LSE:UPR)
Historical Stock Chart
From Apr 2024 to May 2024
Uniphar (LSE:UPR)
Historical Stock Chart
From May 2023 to May 2024